Free Trial
NASDAQ:HSDT

Solana Q2 2025 Earnings Results & Report

Solana logo
$2.38 -0.16 (-6.30%)
Closing price 10/8/2026 04:00 PM Eastern
Extended Trading
$2.46 +0.08 (+3.36%)
As of 07:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Solana beat analyst earnings expectations but missed on revenue in its Q2 2025 results, released August 14, 2025. The company reported EPS of -$79.73 versus the -$128.50 consensus estimate, while revenue of $0.04 million fell short of the $0.11 million estimate by $0.07 million.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens
Conference Call Date
Conference Call
4:00 PM ET

Solana EPS Results

Actual EPS
-$79.73
Consensus EPS
-$128.50
Beat/Miss
Beat by +$48.77
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 5 quarters

Solana Revenue Results

Actual Revenue
$0.04 million
Expected Revenue
$0.11 million
Beat/Miss
Missed by -$70.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Solana's Q3 2026 earnings is estimated for Tuesday, November 17, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Solana Q2 2025 Earnings FAQ

Solana (NASDAQ:HSDT) reported earnings of -$79.73 per share for Q2 2025, beating the consensus estimate of -$128.50. The report was announced on Thursday, August 14, 2025.

Solana reported revenue of $0.04 million for Q2 2025, against a consensus estimate of $0.11 million.

Solana's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Solana on the company's earnings history page.

Solana Earnings Headlines

Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
Comparing PayPal (NASDAQ:PYPL) & Solana (NASDAQ:HSDT)
See More Solana Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solana? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solana and other key companies, straight to your email.

About Solana

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Solana Profile